 |
|
If you need to get a quote for any product, or have any questions, please fill in the
following contact form, we will contact you within 24 hours. If your have an account with us, click here to login to retrieve your information.
| Your Contact Information (Required *) |
| First Name* |
|
| Last Name* |
|
| E-Mail* |
|
| Company Name* |
|
| Address |
|
| City |
|
| State |
|
| Zip |
|
| Country |
|
| Phone |
|
| Fax |
|
| Web Site |
|
| |
| Products Interested (Browsing products) |
|
| Product ID |
CAS Number |
Product Name |
Quantity |
| A1-0139 |
120737-59-9 |
N-1-Boc-3-Methylpiperazine |
|
| AS-1034 |
84358-12-3 |
1-Boc-3-piperidinecarboxylic acid |
|
| AS-1050 |
603-76-9 |
1-Methylindole |
|
| AS-1490 |
142148-13-8 |
(1-HYDROXYMETHYL-CYCLOPROPYL)-ACETIC ACID METHYL ESTER |
|
| AS-1669 |
92339-07-6 |
2,3,5,6-Tetrafluoro-1,4-benzenedimethanol |
|
| AS-1670 |
652-36-8 |
Tetrafluoroterephthalic acid |
|
| AS-2039 |
552-45-4 |
2-Methylbenzyl chloride |
|
| AS-2573 |
4606-65-9 |
3-Piperidinemethanol |
|
| AS-2650 |
42860-02-6 |
3-BROMO-5-CHLOROBENZOIC ACID |
|
| AS-3416 |
2905-21-7 |
2-Fluorobenzenesulfonyl chloride |
|
| AS-4127 |
623-47-2 |
Ethyl propiolate |
|
| AS-4382 |
1978-33-2 |
2-Fluoro-3-methylaniline |
|
| AS-5961 |
83792-47-6 |
N-Fmoc-N'-tosyl-L-arginine |
|
| AS-6697 |
195316-72-4 |
L-Allylglycine |
|
| AS-6704 |
2899-60-7 |
Z-GLY-OSU |
|
| AS-6763 |
1462-12-0 |
DIETHYL ETHYLIDENEMALONATE |
|
| AS-7598 |
95-93-2 |
1,2,4,5-Tetramethylbenzene |
|
| JR6-L1623 |
1014716-82-5 |
Borate(1-), [2-[(hydroxy-O)methyl]-2-methyl-1,3-propanediolato(3-)-O1,O3](4-phenoxyphenyl)-, potassium (1:1), (T-4)- |
|
| JR6-L3373 |
341518-71-6 |
[1,1'-Binaphthalene]-3-carboxaldehyde, 2,2'-dihydroxy- |
|
| JR6-L5083 |
1369404-21-6 |
1,2-Benzenediol, 3-[[(2-methoxyphenyl)amino](2-methyl-1H-indol-3-yl)methyl]- |
|
| JR6-L9296 |
137581-63-6 |
1-Pyrrolidineethanamine, a-phenyl-, (aS)- |
|
| JR8-N0263 |
53963-43-2 |
Ginsenoside F1 |
|
| JR8-N1240 |
120926-46-7 |
Isoliquiritin apioside |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Comments |
| |
|
 |
|
|
|
|
|
|